These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels. Akyuz U; Yesil A; Yilmaz Y Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973 [TBL] [Abstract][Full Text] [Related]
44. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881 [TBL] [Abstract][Full Text] [Related]
47. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection. Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210 [TBL] [Abstract][Full Text] [Related]
48. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. Shen J; Wong GL; Chan HL; Chan HY; Yeung DK; Chan RS; Chim AM; Chan AW; Choi PC; Woo J; Chu WC; Wong VW Aliment Pharmacol Ther; 2014 Mar; 39(5):532-9. PubMed ID: 24417250 [TBL] [Abstract][Full Text] [Related]
49. Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease. Baker PR; Friedman JE J Clin Invest; 2018 Aug; 128(9):3692-3703. PubMed ID: 30168806 [TBL] [Abstract][Full Text] [Related]
50. Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease. Fleet SE; Lefkowitch JH; Lavine JE Gastroenterol Clin North Am; 2017 Jun; 46(2):217-231. PubMed ID: 28506362 [TBL] [Abstract][Full Text] [Related]
51. Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign. Tobari M; Hashimoto E; Taniai M; Ikarashi Y; Kodama K; Kogiso T; Tokushige K; Takayoshi N; Hashimoto N J Gastroenterol Hepatol; 2019 Aug; 34(8):1404-1410. PubMed ID: 30590868 [TBL] [Abstract][Full Text] [Related]
52. Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Sookoian S; Castaño GO; Scian R; Mallardi P; Fernández Gianotti T; Burgueño AL; San Martino J; Pirola CJ Hepatology; 2015 Feb; 61(2):515-25. PubMed ID: 25302781 [TBL] [Abstract][Full Text] [Related]
53. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2. Anstee QM; Day CP Semin Liver Dis; 2015 Aug; 35(3):270-90. PubMed ID: 26378644 [TBL] [Abstract][Full Text] [Related]
54. Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update. Valenti LVC; Baselli GA Curr Pharm Des; 2018; 24(38):4566-4573. PubMed ID: 30659533 [TBL] [Abstract][Full Text] [Related]
55. Maternal obesity has sex-dependent effects on insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring. Lomas-Soria C; Reyes-Castro LA; Rodríguez-González GL; Ibáñez CA; Bautista CJ; Cox LA; Nathanielsz PW; Zambrano E J Physiol; 2018 Oct; 596(19):4611-4628. PubMed ID: 29972240 [TBL] [Abstract][Full Text] [Related]
56. PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress. Carpino G; Pastori D; Baratta F; Overi D; Labbadia G; Polimeni L; Di Costanzo A; Pannitteri G; Carnevale R; Del Ben M; Arca M; Violi F; Angelico F; Gaudio E Sci Rep; 2017 Nov; 7(1):15756. PubMed ID: 29150621 [TBL] [Abstract][Full Text] [Related]
57. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. Del Ben M; Polimeni L; Brancorsini M; Di Costanzo A; D'Erasmo L; Baratta F; Loffredo L; Pastori D; Pignatelli P; Violi F; Arca M; Angelico F Eur J Intern Med; 2014 Jul; 25(6):566-70. PubMed ID: 24947770 [TBL] [Abstract][Full Text] [Related]
58. Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status. Oniki K; Watanabe T; Kudo M; Izuka T; Ono T; Matsuda K; Sakamoto Y; Nagaoka K; Imafuku T; Ishima Y; Watanabe H; Maruyama T; Otake K; Ogata Y; Saruwatari J CPT Pharmacometrics Syst Pharmacol; 2018 Jun; 7(6):384-393. PubMed ID: 29569850 [TBL] [Abstract][Full Text] [Related]
59. Nutritional, pharmacological, and environmental programming of NAFLD in early life. Galvan-Martinez DH; Bosquez-Mendoza VM; Ruiz-Noa Y; Ibarra-Reynoso LDR; Barbosa-Sabanero G; Lazo-de-la-Vega-Monroy ML Am J Physiol Gastrointest Liver Physiol; 2023 Feb; 324(2):G99-G114. PubMed ID: 36472341 [TBL] [Abstract][Full Text] [Related]
60. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome. Stättermayer AF; Traussnigg S; Aigner E; Kienbacher C; Huber-Schönauer U; Steindl-Munda P; Stadlmayr A; Wrba F; Trauner M; Datz C; Ferenci P J Trace Elem Med Biol; 2017 Jan; 39():100-107. PubMed ID: 27908400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]